Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court Meghna A Singhania3 May 2019 1:50 PM ISTMumbai:In a court setback to many big drugmakers in India, a petition filed by pharma majors including Biocon, Wockhardt, Lupin and Cadila Healthcare...
Zydus Cadila gets USFDA nod to market 2 generic drugs Medical Dialogues Bureau1 May 2019 8:05 PM ISTNew Delhi: Drug firm Zydus Cadila Tuesday said it has received the final nod from the USFDA to market generic Bosentan tablets and Trientine...
CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India Farhat Nasim30 April 2019 10:15 AM IST"SIFI's innovative IOLs (Intraocular lenses) have been approved by the Indian Central Drugs Standards Control Organisation(CDSCO) (Directorate General...
Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis Farhat Nasim26 April 2019 12:49 PM ISTLeflunomide tablet is used to treat rheumatoid arthritis, a condition affecting multiple small and large joints of the body.New Delhi: Drug firm Zydus...
Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tablets Meghna A Singhania22 April 2019 2:07 PM ISTAHMEDABAD: In a major setback, three Gujarat based pharmaceutical companies including Cadila Healthcare, West Coast Pharmaceutical Works Ltd and Maan...
Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia Farhat Nasim17 April 2019 9:45 AM ISTZydus Cadila Group Chairman Pankaj R Patel said this innovation has the potential to bring about a paradigm shift in the management of CKD patients...
Zydus Cadila gets tentative USFDA nod to Tofacitinib tablets for treating arthritis Farhat Nasim6 April 2019 3:00 PM ISTTofacitinib is used alone or with other medications to treat moderate to severe forms of rheumatoid arthritis, the company said in a BSE filing. New...
Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder Farhat Nasim2 April 2019 11:50 AM ISTThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release...
Zydus Wellness to sell shares worth Rs 2575 crore to Cadilla and three others Medical Dialogues Bureau29 Jan 2019 9:20 AM ISTIn a tweet Friday, the Competition Commission of India (CCI) said it "approves the acquisition of shares in Zydus Wellness Limited by True North...
Cadila Healthcare arm gets USFDA nod to market Ranitidine injection Medical Dialogues Bureau12 Dec 2018 10:00 AM ISTNEW DELHI: Drug firm Cadila Healthcare on Tuesday said its subsidiary has received approval from the US health regulator to market Ranitidine...
Kraft Heinz to Sell Indian Brands Complan, Glucon-D, Nycil and Sampriti to Zydus Wellness Limited Medical Dialogues Bureau25 Oct 2018 10:01 AM ISTNew Delhi: The Kraft Heinz Company announced that it has entered into a definitive agreement to sell Indian brands Complan, Glucon-D, Nycil and...
Cadila gets USFDA nod for generic drug to treat Parkinson Ruby Khatun Khatun15 Dec 2017 4:08 PM ISTNew Delhi: Cadila Healthcare said it has received approval from the US health regulator to market Pramipexole Dihydrochloride extended-release...
